Tegenero official site, as archived at the Internet Archive
TeGenero sinks.The article reports on the failure of clinical trials conducted by W眉rzburg, Germany-based TeGenero AG for its drug TGN1412, which was developed to dampen the immune system. Six healthy people almost died during the clinical trials due to adverse reactions caused by the drug....
The article reports on the failure of clinical trials conducted by Würzburg, Germany-based TeGenero AG for its drug TGN1412, which was developed to dampen the immune system. Six healthy people almost died during the clinical trials due to adverse reactions caused by the drug. The purpose of ...
TeGenero Mab causes shock side-effects in UK trial.The article reports on the outcome of the phase I clinical trial of TeGenero AG's TGN1412 held in Great Britain which created a controversy after patients suffered serious harmful effects after taking the drug. They revealed that six men ...
Te domina el Pop o K-Pop Eres una persona que es apasionada, sociable y tienes mucho carisma. ✨🎤 Además de ser un fan apasionado, amas escuchar lo que está en tendencia, te gusta bailar y cantar a todo pulmón, aunque no lo hagas tan bonito, jiji. Si es cierto, amo...
Te domina el reguetón o el rap Amas escuchar canciones en español de estos géneros, así como disfrutar de las noches bailando hasta tarde con tus amiguis. Sabes con qué canciones transmitir tu mal de amores o cuáles dedicarle a tu crush. 👌🔥 Solo acertó en una o dos...
Sheridan, C., TeGenero fiasco prompts regulatory rethink. Nat Biotechnol, 2006. 24(5): p. 475-6.Sheridan, C. (2006) TeGenero fiasco prompts regulatory rethink. Nat Biotechnol 24 (5), 475-476Sheridan, C. 2006. TeGenero fiasco prompts regulatory rethink. Nat. Bio- technol. 24:475-476....
Sheridan, C., TeGenero fiasco prompts regulatory rethink. Nat Biotechnol, 2006. 24(5): p. 475-6.Sheridan C. TeGenero fiasco prompts regulatory rethink. Nat Biotechnol, 2006, 24(5):475-476.C. Sheridan, "TeGenero fiasco prompts regulatory rethink," Nature Biotechnology, vol. 24, no. 5,...
The article reports on the failure of clinical trials conducted by Würzburg, Germany-based TeGenero AG for its drug TGN1412, which was developed to dampen the immune system. Six healthy people almost died during the clinical trials due to adverse reactions caused ...
The article reports that TeGenero AG has filed for bankruptcy. The company cites unforeseen adverse reaction as the cause. The company noted that the fallout from the crisis made it impossible to attract the investment it needed to continue in business. ...